Stock CTX CRESCITA THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Crescita Therapeutics Inc.

Equities

CTX

CA2258471028

Market Closed - Toronto S.E.
Other stock markets
 20:41:30 28/06/2024 BST 		5-day change 1st Jan Change
0.53 CAD +15.22% Intraday chart for Crescita Therapeutics Inc. +21.84% +8.16%
06-26 Crescita Therapeutics Brief: Says Completed Acquisition of Strategic Assets of Occy Laboratory MT
06-26 Crescita Therapeutics Inc. completed the acquisition of Assets of Occy Laboratory for CAD 0.9 million. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Crescita Therapeutics Brief: Says Completed Acquisition of Strategic Assets of Occy Laboratory
MT
Crescita Completes Acquisition of Strategic Assets of Occy Laboratory
BU
Crescita Therapeutics Inc. completed the acquisition of Assets of Occy Laboratory for CAD 0.9 million.
CI
Crescita Therapeutics Agrees to Buy Strategic Assets of Occy Laboratory
MT
Crescita to Acquire Strategic Assets of Occy Laboratory
BU
Crescita Therapeutics Brief: Says to Acquire Strategic Assets of Occy Laboratory
MT
Crescita Therapeutics Inc. agreed to acquire Assets of Occy Laboratory Inc.
CI
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
BU
Crescita Therapeutics Q1 Loss Widens, Revenue Rises
MT
Crescita Therapeutics Brief: Q1 Revenue was $4.996 Million
MT
Tranche Update on Crescita Therapeutics Inc.'s Equity Buyback Plan announced on August 29, 2023.
CI
Crescita Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Crescita Reports First Quarter 2024 Results
BU
Crescita Therapeutics Reports Q4 Net Loss of $0.01 Per Share
MT
Tranche Update on Crescita Therapeutics Inc.'s Equity Buyback Plan announced on August 29, 2023.
CI
Crescita Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Crescita Therapeutics Brief: Q4 EPS Basic and Diluted Loss $0.01
MT
Crescita Reports Q4 and Fiscal 2023 Results
BU
Crescita Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
North American Morning Briefing : Stock Futures -2-
DJ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CTX Stock
  4. News Crescita Therapeutics Inc.